Heterogeneity of management practices surrounding operable gallbladder cancer - results of the OMEGA-S international HPB surgical survey.

F. Daams | A. Jah | T. Dumitrașcu | D. Magouliotis | T. Gruenberger | F. Giuliante | S. Maithel | A. Banerjee | V. Kosmoliaptsis | P. Karanicolas | T. Giuliani | J. Koong | D. Radenkovic | P. Gibbs | R. Praseedom | A. Nickkholgh | A. Ivanecz | M. Adham | M. Lesurtel | D. Zacharoulis | A. Rammohan | D. Hughes | K. Tepetes | E. Lolis | Avishek Anand | C. Sturesson | G. Tsoulfas | E. Felli | F. Primavesi | A. Komorowski | J. Sakata | F. Giannone | F. Giovinazzo | R. Kalayarasan | S. Aroori | A. Alseidi | S. Harper | S. Liau | E. Huguet | J. Ramia | B. Goh | S. Mayo | S. Famularo | M. Di Martino | C. Schena | C. Schwarz | A. Mahamid | Z. Yang | G. Desai | P. Antonakis | K. Perivoliotis | S. Heinrich | B. Al-Sarireh | A. Gulla | C. Noel | M. Goel | A. Serrablo | O. Ciacio | D. Malde | M. Barabino | E. M. Muttillo | A. Porcu | R. Bhojwani | L. Kaman | Y. Limbu | T. Błaż | G. Zimmitti | V. Velayutham | A. Karayiannakis | D. Cavallucci | N. Pararas | P. Kolodziejczyk | E. Sparrelid | E. Giorgakis | J. Lendoire | P. Kron | S. Státtner | S. Helton | H. Kanhere | F. Ausania | A. Thepbunchonchai | M. Fergadi | G. B. Fernández | F. Alconchel | J. Périnel | F. Bartsch | M. Giuffrida | M. Dixon | M. Machairas | B. Dasari | D. O’Reilly | G. Gemenetzis | X. de Aretxabala | J. Omoshoro-Jones | E. Pueyo-Périz | L. Lundgren | S. Pandanaboyana | S. Van Laarhoven | A. Perfecto | P. Koh | S. Patkar | A. Laurenzi | A. Rowcroft | O. Guevara | M. Marino | G. Malleo | T. Perra | D. Galun | Hks Hamid | I. Gkekas | R. Sutcliffe | J. Lanari | A. Troncoso | J. Erdmann | A. Nikov | L. Gil | S. Iype | R. Memeo | E. Saladino | V. D. de Meijer | L. Viganò | A. Heumann | P. Clavien | M. Nandasena | V. Yip | E. Arabadzhieva | M. Alsammani | V. M. Leow | F. Mulita | A. Kaldarov | V. Lopez-Lopez | M. S. Eilard | S. Galodha | B. Bjornsson | A. Balakrishnan | M. Achalandabaso | P. Nashidengo | C. Tovikkai | P. Dorovinis | P. Serrano | J. Peng | J. Beristain-Hernández | S. Ashley | T. Abe | G. Deiro | C. Nahm | F. Berrevoet | A. Ahmet | S. Lob | K. Kacirek | A. Scholer | D. Moris | M. Mazzola | A. Anselmo | M. Phan | M. Calvo | H. Morgul | A. Gomes | R. Higuchi | I. Kozyrin | F. D’amico | A. Hakeem | T. Vanagas | B. Andersson | A. Di Gioia | H. Malik | A. Brañes | J. Primrose | A. Belli | J. Torres | R. Menzulin | A. Gupta | V. Kapoor | D. Chang | G. Piccolo | Z. A. Khan | M. J. Castro | M. Byrne | R. Lozano | J. Klose | J. Teo | M. Erkan | G. Tzimas | T. Ebata | K. Søreide | L. Urbani | K. Menon | P. Lakhey | R. Gupta | A. Kausar | Akanxa Bhatti | M. Albiol Quer | R. Alejandro | A. Bartlett | J. Castellanos | G. Christodoulis | A. Coker | M. Conde-Rodriguez | M. D'hondt | M. De Beillis | K. Dede | F. Delgado | A. Fox | S. Ganandha | Roni Garcia | B. C. Inarejos | Y. Iwao | I. Jaen | M. Jie | R. Jones | D.-S. Kim | B. Knowles | A. Krishna | N. Kumar | Y.‐B. Liu | A. Malek | R. Mohan | T. O'Rourke | M. Ohtsuka | R. Patel | M. Silva | T. Sugiura | M. Sumo | C. Teh | P. Thapa | O.J.M. Torres | G. Torzili | A. Tuzuher | G. I. Umar | Varga | T. Wakai | E. Zakharov | F. Mulita | P. R. Nashidengo | R. Gupta | R. Jones

[1]  T. Sachs,et al.  Lymphadenectomy in gallbladder adenocarcinoma: Are we doing enough? , 2021, American journal of surgery.

[2]  A. Sachan,et al.  Bi-segmentectomy versus wedge hepatic resection in extended cholecystectomy for T2 and T3 gallbladder cancer: A matched case-control study , 2021, Annals of hepato-biliary-pancreatic surgery.

[3]  A. Ramaswamy,et al.  Revision Surgery for Incidental Gallbladder Cancer—Challenging the Dogma: Ideal Timing and Real-World Applicability , 2021, Annals of Surgical Oncology.

[4]  J. Bader,et al.  Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer , 2021, Annals of Surgical Oncology.

[5]  Hong-Mei Yu,et al.  Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. , 2021, Surgery.

[6]  Jin‐Young Jang,et al.  T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences , 2021, Virchows Archiv.

[7]  Masahiro Yoshida,et al.  Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition , 2020, Journal of hepato-biliary-pancreatic sciences.

[8]  E. Zubizarreta,et al.  The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[9]  Fei Liu,et al.  Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China , 2020, Surgical Endoscopy.

[10]  Chiu-Hsieh Hsu,et al.  Gallbladder Cancer Surgery in the United States: Lymphadenectomy Trends and Impact on Survival. , 2020, The Journal of surgical research.

[11]  A. S. Lima,et al.  BRAZILIAN CONSENSUS ON INCIDENTAL GALLBLADDER CARCINOMA , 2020, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[12]  R. Warschkow,et al.  Effect of lymphadenectomy in curative gallbladder cancer treatment: a systematic review and meta-analysis , 2020, Langenbeck's Archives of Surgery.

[13]  I. Endo,et al.  Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium , 2020, Journal of surgical oncology.

[14]  S. Hiotis,et al.  Staging gallbladder cancer with lymphadenectomy: the practical application of new AHPBA and AJCC guidelines. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[15]  S. Maithel,et al.  Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  E. Viñuela,et al.  Minimally Invasive Surgery for Gallbladder Cancer. , 2019, Surgical oncology clinics of North America.

[17]  K. Søreide,et al.  Systematic review of management of incidental gallbladder cancer after cholecystectomy , 2018, The British journal of surgery.

[18]  A. Nanashima,et al.  Significance of bile duct resection for advanced gallbladder cancer without biliary infiltration. , 2018, American journal of surgery.

[19]  D. Candinas,et al.  High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis. , 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[20]  X. Aretxabala,et al.  Incidental Gallbladder Cancer: How Residual Disease Affects Outcome in Two Referral HPB Centers from South America , 2018, World Journal of Surgery.

[21]  M. Spada,et al.  Minimally invasive surgical approach for radicalization of incidental post-cholecystectomy gallbladder carcinoma: safety, feasibility and outcomes , 2018, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[22]  Yoo-Seok Yoon,et al.  Survey Results of the Expert Meeting on Laparoscopic Surgery for Gallbladder Cancer and a Review of Relevant Literature , 2018, Digestive Surgery.

[23]  Yoo-Seok Yoon,et al.  Laparoscopic Surgery for Gallbladder Cancer: An Expert Consensus Statement , 2018, Digestive Surgery.

[24]  S. Natsugoe,et al.  Indication of extrahepatic bile duct resection for gallbladder cancer , 2018, Langenbeck's Archives of Surgery.

[25]  T. Pawlik,et al.  Routine port‐site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi‐institution analysis from the US Extrahepatic Biliary Malignancy Consortium , 2017, Journal of surgical oncology.

[26]  Marina F Englesakis,et al.  Trends in port‐site metastasis after laparoscopic resection of incidental gallbladder cancer: A systematic review , 2017, Surgery.

[27]  A. Strandell,et al.  Surgical treatment for gallbladder cancer – a systematic literature review , 2017, Scandinavian journal of gastroenterology.

[28]  W. Jarnagin,et al.  Gallbladder cancer: expert consensus statement. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[29]  H. S. Shukla,et al.  Indian Council of Medical Research consensus document for the management of gall bladder cancer , 2015, Indian Journal of Medical and Paediatric Oncology.

[30]  T. Takada,et al.  Gallbladder bed resection or hepatectomy of segments 4a and 5 for pT2 gallbladder carcinoma: analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2013, Journal of hepato-biliary-pancreatic sciences.